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the interplay with surrounding water. The hydrophobic force driving the oligomerization causes water removal from interfaces,
changing the surface-hydration properties. Here, we show that such effects alter the magnetic relaxation response of local water
in ways that may enable oligomer detection. By using water protonmagnetic resonance spectroscopy, wemeasured significantly
longer transverse magnetic relaxation (T2) times in mixtures of serum and amyloidogenic Ab1-42 peptides versus similar concen-
tration solutions of serumand nonamyloidogenic scrambledAb42-1 peptides. Immunochemistrywith oligomer-specific antibodies,
electron microscopy and computer simulations demonstrated that the hyperintense magnetic signal correlates with Ab1-42
oligomerization. Finding early biophysical markers of the oligomerization process is crucial for guiding the development of new
noninvasive imaging techniques, enabling timely diagnosis of amyloid-related diseases and pharmacological intervention.INTRODUCTIONAmyloids are proteinaceous fibrils that can be derived by the
aggregation of a large variety of proteins (1). Accumulation
of amyloids in susceptible tissues represents the common
manifestation of many degenerative diseases (2,3). Well-
known examples (1–4) include deposition of Ab fibrillar
plaques in the brains of Alzheimer’s disease (AD) patients,
accumulation of islet amyloid polypeptide (IAPP) fibrils in
pancreatic islets of type-2 diabetics, and formation of serum
protein transthyretin deposits in cardiac tissues (the hall-
mark of heart amyloidoses).
There is emerging clinical and experimental evidence
(5,6) suggesting that the occurrence of amyloid deposits
could actually be a defense mechanism used to avoid serious
tissue degradation whereas the major toxic effects to cells
are mediated by soluble amyloid oligomers. Data collected
from various human pathological tissues, including AD
brain (7), diabetic pancreatic islets (8), and failing hearts
(9,10), show that soluble amyloid oligomers are distinct,
spatially segregated molecular entities. They presumably
attach to cellular membranes, inducing cell dysfunction
and apoptosis (8), or aggregate-forming fibril bundles (7).
Early detection of amyloid oligomers is crucial for treating,
inhibiting the progression, and preventing devastating
effects of amyloid-related diseases.
The amyloid oligomer represents an amorphous molec-
ular aggregate formed by the association of small numbers
(tens or fewer) of amyloid monomers (11,12). Molecular-
dynamics simulations in explicit solvent show that soluble
oligomer species consist actually of various b-barrel struc-
tures in equilibrium with amorphous states and fibrillike
assemblies (13). Immunochemistry with conformation-Submitted February 1, 2011, and accepted for publication March 25, 2011.
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preamyloid species is the result of competing reaction path-
ways that are thermodynamically distinct (14).
Temperature, concentration, and solvent conditions can
have a strong impact on the structure and dynamics of these
molecular species, in vitro (15,16). Formation and accumula-
tion of amyloidogenic entities in vivo are more complex,
because these entities are also potentially membrane-inter-
acting (reviewed by Meredith (17)). From the point of view
of aggregation, conditions that favor binding of the protein
to membranes also disfavor formation of isolated fibrils, sug-
gesting that these two processes are opposed to one another.
Cell membranes can act indeed as sites of accumulation for
amyloidogenic peptides (17), such as IAPP, favoring IAPP
fibril growth at the membrane (18). On the other hand, recent
studies revealed the presence of IAPP oligomers in secretory
vesicles of pancreatic b-cells (8,19,20), blood, and heart
tissues (10), suggesting that IAPP oligomers can travel
through the circulation system as distinct entities.
Amyloid oligomer formation is critically coupled to the
interplay with surrounding water. The force driving amyloid
monomers to oligomerize is mostly hydrophobic in nature,
causing water removal from interfaces and changing the
surface-hydration properties. Thus, oligomerization can
alter the bulklike/surface-water ratio and induce rearrange-
ments of local solvent networks in ways that may enable
oligomer detection. Previous studies suggested that surface
hydration properties of proteins determine the microscopic
magnetic relaxation response of surrounding water (21–24).
Recently, Nucci et al. (24) demonstrated that water proton
magnetic resonance spectroscopy can resolve dynamics of
water at the surface of proteins. Moreover, the results (24)
suggest that water-rearrangement processes in the next
hydration layers closely correlate with hydration properties
of specific water patches on the protein surface (25), whichdoi: 10.1016/j.bpj.2011.03.029
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work by Nucci et al. (24) supports also the idea (21–23) that
the magnetic relaxation of water in the hydration shells of
proteins is a valuable tool to probe pathogenic proteins asso-
ciated with many diseases.
Here, we investigate the magnetic relaxation response of
water in mixtures of serum and amyloidogenic Ab1-42
peptides versus similar concentration solutions of serum
and nonamyloidogenic scrambled Ab42-1 peptides by using
water proton magnetic resonance spectroscopy (MRS).
Immunochemistry with oligomer-specific antibodies, elec-
tron microscopy, and computer simulations are used to
uncover the most likely amyloid structures associated with
the magnetic signal recorded in each protein mixture. This
study may give a new impetus to the development of
efficient experimental protocols for early detection of
amyloid-related diseases.MATERIALS AND METHODS
The key experimental factor in the water proton MRS approach used by
Nucci et al. (24) is the encapsulation of proteins in small cages, e.g., in
reverse micelles (28), to slow hydration dynamics and hydrogen-exchange
kinetics of proteins. Increasing the fraction of local water protons with
slower reorientations along the applied magnetic field compared with the
ultrafast reorientation of bulklike water protons enables protein detection
(25). Based on these facts, we assume that amyloid oligomer formation
in a low viscosity fluid, e.g., serum, can alter significantly the fraction of
bulklike/surface water to induce a distinct magnetic resonance signal.
The following basic question is being addressed. Assume a system of N
background serum proteins in a given environment of volume V. Suppose
we replace DN serum proteins with amyloidogenic Ab1-42 peptides. The
amyloidogenic peptides associate, forming soluble amyloid oligomers
and protofibrils. The Ab1-42 oligomerization process can alter bulklike/
surface water, change surface-hydration properties, and induce rearrange-
ments of local water networks. In contrast, the replacement of serum
proteins by (the same amount of) nonamyloidogenic Ab42-1 isomers may
not alter significantly dynamics of water molecules, because Ab42-1 does
not oligomerize.
What is the relative change of water proton magnetic relaxation time (T2)
after morphological transitions from monomers to soluble amyloid species?
To answer this question, we combine experimental approaches, including
water proton MRS, immunochemistry with oligomer-specific antibodies







scrambled isoforms are test peptides (from Anaspec, Fremont, CA) in this
study. As protein background, we used bovine serum, a biological mediumcontaining mainly water (~90%) and bovine serum albumin proteins. Stock
peptide solutions were mixed with bovine serum at final peptide concentra-
tions of 5, 50, and 100 mM in a 0.7-mL volume. All protein solutions, i.e.,
mixtures of serum and amyloidogenic or nonamyloidogenic peptides or just
serum, were prepared at the same volume (0.7 mL), pH, and temperature
conditions. Sodium azide (0.02%) was added in solutions to prevent
microbial growth. Protein solutions were incubated at room temperature
for 3 h, without stirring, to allow the amyloidogenic peptides to associate
and form oligomers and fibrils.
Prior measurements, protein solutions were transferred in 5-mm high-
resolution NMR tubes. The proton transverse magnetic relaxation time
(T2) decay in each protein sample was measured at 3 h after starting the
aggregation reaction and repeated next day (~24 h). The measurements
were done with a 9.4 T MR scanner (Oxford Instruments, Abingdon, Ox-
fordshire, UK) with an 89-mm-wide-bore magnet. To capture the essential
characteristics of the magnetic relaxation response of the solvation water,
we used a Carr-Purcell-Maiboom-Gill T2 relaxation pulse sequence with
a 1-ms echo spacing and an echo train length of 1 s. T2 decay curves
were analyzed with a nonnegative least-squares algorithm to derive the
characteristic T2 time of the magnetic signal (29).
To uncover the most likely amyloidogenic entities associated with the
T2-MR signal in each protein solution, we carried out dot-blot assays using
conformation-dependent antibodies. Immunochemistry tests with confor-
mation-dependent antibodies provide direct evidence for oligomer and fibril
formation (7,14). The anti-oligomer-specific antibody A11 recognizes
the nonfibrillar oligomeric conformation, but not the monomer or the
fibrillar oligomeric structures (7–9,14). Conversely, the anti-fibril-specific
antibody OC recognizes the fibrillar oligomers (protofibrils), but not
nonfibrillar oligomers or monomers (14). The dot-blot assay is a technique
for detecting, analyzing, and identifying proteins. Briefly, 2-mL aliquots of
each oligomerization reaction are applied onto nitrocellulose membranes.
The membranes are blocked for 1 h at room temperature (RT) or overnight
at 4C with 10% nonfat milk in Tris-buffered saline containing 0.01%
TWEEN 20. (TWEEN 20 is a detergent used for solubilizing proteins.)
The membranes are then washed in 0.01% TWEEN 20 and incubated
with affinity-purified conformation-dependent antibodies for 1–2 h at RT.
Membranes are washed again and incubated with a secondary antibody
(horseradish peroxidase-conjugated) for 1 h (RT). Then, the membranes
are washed and developed with an electrochemiluminescence kit. Data
were collected at the initial time point (3 h) as for the T2-MR measurement
and, afterwards, repeated daily for up to three days, to monitor morpholog-
ical changes in the protein solutions. For assessing the clumps of amyloid
fibrils and amyloid deposition, we measured the Thioflavin T (ThT)
fluorescence in amyloidogenic protein samples at three days after starting
the oligomerization reactions. For measurements in solutions, we used
a microplate-reader fluorometer with excitation at 458 nm (Ar laser) and
fluorescence collected at >475 nm. The fluorescence intensity was
corrected for background and normalized using the baseline serum fluores-
cence level.
To visualize the nature of molecular entities formed in solutions, aliquots
of each aggregation reaction were imaged by a CM 12 electron microscope
(Philips Electron Optics, FEI, Hillsboro, OR) at the same time points as for
dot blot and water proton MRS measurements. Electron microscopy (EM)
images were taken also at the end point of the oligomerization process to
visualize amyloid deposition. Specimen preparation followed the procedure
described in the article of Paravastu et al. (30). Clumping of protofibrils and
amyloid fibril deposition in solutions were also assessed also by ThT fluo-
rescence by using a microplate-reader fluorometer, with excitation at
450 nm and emission at 482 nm.Theoretical
The characteristic relaxation rate of water depends on the motion of water
molecules through the spectral density function. The spectral density func-
tion is usually approximated by the LorentzianBiophysical Journal 100(9) 2302–2308
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1þ ðu tÞ2;
where u is the frequency of the applied field and t represents the rotational
relaxation time of water molecules in the local environment. Because the
oligomerization process alters significantly the surface/bulk water, we
considered here two main water pools in each protein system, surface
(Xs) and bulk-like (Xb) waters. The characteristic rotational relaxation times
for surface and bulk water molecules are approximated by tSy 10
10 s and
tb y 10
12 s (22,28), respectively.
Normally, the recorded signal is a superposition of the relaxation
responses from these two water phases (22,28):
1
T2
¼ XS C ½3 tS þ 5 JðuL; tSÞ þ 2 Jð2 uL; tSÞ
þ Xb C ½3 tb þ 5 JðuL; tbÞ þ 2 Jð2 uL; tbÞ:
(1)
Here, C stands for the strength of the magnetic dipole-dipole coupling (Cy
8 109 s2) and uL represents the Larmor frequency of the water protons in
the magnetic field of theMR scanner. The Larmor frequency depends on the
intensity of the magnetic field (B0) and proton gyromagnetic ratio (g ¼
2.675108 s1 T 1), uL ¼ g B0, where B0 ¼ 9.4 T.
Water molecules at the interface with amyloidogenic peptides undergo
considerable reorganization during the aggregation process (11,12,21–
23,31,32). As the peptides associate forming oligomers and fibrils, their
hydrophobic patches are buried inside the newly formed amyloidogenic
assembly. This gradually liberates more water molecules into the bulklike
water phase, decreasing the fraction of water molecules in direct contact
with the molecular surface (21–23). Based on the scaled particle theory
(33), we can estimate the amount (DV) of surface water released in the
bulk after the oligomerization process.
According to this theory, the intrinsic volume (Vm) of a macromolecule
plus a shell of thickness l which results from the mutual thermal motions
of the macromolecule and neighbor water molecules form the partial
volume V0, V0 y Vm þ asa l, where asa represents the water-accessible
surface area of the monomer. V0 is roughly 1.11 Vm (22), so the thickness




and the volume of water at the macromolecular surface becomes Vs y
0.11 Vm. The amount of water in the hydration shells of the amyloidogenic
proteins is roughly equal to DN 0.11 Vm. Let us now assume that all DN
amyloidogenic proteins clustered together, forming an aggregate with the
water-accessible surface area ASA. Although the total amount of surface
water of the newly formed molecular structure may depend on the structural
morphology, the thickness (l) of the hydration shell remains in the same
range as for individual peptides,TABLE 1 T2 magnetic relaxation times in mixtures of amyloidogeni
of nonamyloidogenic AbS in serum (experimental and computation
Peptide concentration in serum Solutions
100 mM Ab 311 mL stock Ab
100 mM AbS 311 mL stock AbS
50 mM Ab 155 mL stock Ab
50 mM AbS 155 mL stock AbS
5 mM Ab 16 mL stock Ab
5 mM AbS 16 mL stock AbS
700 mL serum
Baseline T2 time in the theoretical approach was set to 200 ms (serum).
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:Therefore, we can approximate the amount of water in the surface layer of





For simplicity, we can consider that
ASA
asa
scales with (DN)2/3, hence the volume of water confined at the surface of the
composite can be written as
Vsy0:11 ðDNÞ2=3Vm:
Therefore, the fraction DX ¼ DV/V of water released in the bulk after the
aggregation of DN amyloidogenic is given by
DXy
0:11 DNVm  0:11 ðDNÞ2=3Vm
V
: (2)
Obviously, the fraction of surface water corresponding to an amyloidogenic
protein system in oligomeric form is significantly smaller than that
corresponding to the same system in which the amyloidogenic peptides
are in monomeric forms. The relative change of surface and bulklike water
fractions XS/ XS – DX and Xb/ Xb – DX rescale the transverse magnetic
relaxation time T2 / T2 þ DT2. By using Eqs. 1 and 2, we can readily
express the relative change of the magnetic relaxation time DT2/T2 in terms
of the initial T2, when all proteins were in monomeric forms, and DX by
DT2
T2
yDX C ½3 tS þ 5 JðuL; tSÞþ 2 Jð2 uL; tSÞ  3 tb
 5 JðuL; tbÞ  2 Jð2 uL; tbÞT2:
(3)
RESULTS
Water proton T2 was derived from the characteristic MR
signal decay curve of each amyloidogenic/nonamyloido-
genic peptide system. T2 is in the time domain measured
typically in serum, i.e., hundreds of milliseconds (Table 1).
However, the replacement of background serum proteins
with amyloidogenic Ab1-42 (Ab) peptides increased signifi-
cantly the T2 of the surrounding water. In contrast, similar
amounts of nonamyloidogenic scrambled Ab42-1 (AbS)
peptides in serum induced no detectable T2 change. At thec Ab peptides and serum versus same concentration solutions
al data)
Water T2 (exp.) T2 (theoretical)
389 mL serum 3635 7 ms 374 ms
389 mL serum 2005 1 ms
545 mL serum 3175 7 ms 321 ms
545 mL serum 2005 1 ms
684 mL serum 2055 7 ms 208 ms
684 mL serum 1935 7 ms
2005 1 ms
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tions, significant changes of water proton T2 were observed
starting from 2% volume fraction of stock Ab peptide
solution (Table 1).Longer T2 of water correlates with amyloid
oligomer formation
In Fig. 1 a, we display the increase (DT2) of the transverse
magnetic relaxation time induced by the replacement of
serum proteins with amyloidogenic Ab peptides versus
same amounts of nonamyloidogenic AbS isomers. DT2 is
significantly larger at higher Ab volume fractions. Intrigu-
ingly, measured T2-MR signal remained nearly constant in
all protein mixtures for>24 h of incubation at room temper-
ature, as we can see in Fig. 1 b.
To uncover the most likely amyloid species associated
with the T2 signal in each protein solution, we carried out
dot blot assays using conformation-dependent antibodies
(7,14). Aliquots were removed at various time points,
spotted onto nitrocellulose membranes, and probed with
A11 and OC conformation-specific antibodies. The aggre-
gation process developed time-dependent immunoreactivity
that became strongly visible after ~3 h, indicative of the
oligomerization process (Fig. 1 c). The intensity of each
dot in Fig. 1 c reflects the amount of nonfibrillar oligomers
(left-hand group) and fibrillar structures (right-hand group)















































































concentration. Ab-serum mixtures contain heterogeneous populations of nonfib
formation in Ab-serum mixtures. The fibril formation was assessed three daysheterogeneous populations of soluble amorphous and
fibrillar oligomers, suggesting that these amyloid species
are distinct and competing pathways (11).
Population densities of soluble oligomers and protofibrils
increase with peptide concentration. The immunoreactivity
signal remained fairly stable for up to three days. After three
days of incubation at RT, we measured slightly decreased
A11 (amorphous) and OC (fibril) specific immunoreactiv-
ities that can be attributed to the weakened binding of the
amyloidogenic molecular entities to the nitrocellulose
membranes caused by increased clumping and amyloid
deposition. The relatively low kinetics of the conversion
of amyloid monomers into fibrils and fibrillar clumps may
be due to the presence of serum proteins that act as a buffer,
lowering the cross-section area of the Ab-Ab intermolecular
interactions. Clumping of protofibrils and amyloid fibril
deposition in solutions were assessed by ThT fluorescence
(see Fig. 1 d) and EM imaging (Fig. 2 b).
To visualize the nature of the molecular entities formed in
solutions, aliquots of each aggregation reaction were
imaged by transmission EM at the same time points as for
dot blots and water proton T2-MR measurements. Consis-
tent with the immunochemistry tests, protein mixtures
containing large amounts (100 mM) of amyloid peptides
exhibited considerable aggregation reactions at ~24 h of
incubation time. Specifically, the EM images (Fig. 2 a)
show large amounts of amorphous aggregates (indicated




FIGURE 1 (a) Increase DT2 of transverse
magnetic relaxation time in Ab1-42 amyloidogenic
protein systems relative to the magnetic signal in
mixtures of serum and nonamyloidogenic isoform
Ab42-1. The value DT2 is significantly larger in
serum mixtures containing increased concentra-
tions of amyloidogenic peptides, a consequence
of a much faster oligomerization process. (b)
Mean signal intensity amplitudes and T2 magnetic
relaxation times (and characteristic standard errors)
corresponding to water protons in Ab-serum
mixtures. Data are averages of the initial measure-
ments, i.e., 3 h incubation time, and measurements
at 24 h incubation time. The relative variation of
the MR signal indicates that the formation of prea-
myloid species is a dynamic process in which the
oligomers frequently undergo structural transi-
tions. (c) Nonfibrillar oligomer-specific reactivity
(left-hand group) and fibrillar oligomer-specific
reactivity (right-hand group) from dot-blot assays
using conformation-dependent antibodies. The
anti-oligomer-specific antibody A11 recognizes
the oligomeric conformation and not the monomer
or the incipient fibrillar structure. Conversely, the
anti-fibril-specific antibody OC recognizes the
fibril, but not fibrillar oligomers or monomers.
The intensity of each dot reflects the amount of
fibrillar and nonfibrillar oligomers present in each
reaction mixture. This increases with the peptide
rillar and fibrillar preamyloid species. (d) ThT fluorescence revealing fibril
after the Ab-serum incubation at RT.
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50 nm
100 μM amyloidogenic peptides in 
serum (24h incubation time)
a
50 nm
100 μM amyloidogenic peptides in 
serum (72h incubation time)
b
FIGURE 2 (a) Representative transmission EM image of Ab-serum
mixtures. Consistent with the immunochemistry tests, protein mixtures con-
taining large amounts (100 mM) of amyloid monomers exhibited consider-
able aggregation reactions at ~24 h of incubation time. We can see early
forms of elongated oligomers, i.e., protofibrils (arrows) and spheroidal
structures of amorphous amyloid oligomers (bars). (b) Representative
transmission EM image of Ab-serum mixtures, three days after incubation
at RT. Ab formed large amyloid structures. Background serum proteins are
most likely involved in Ab fibril formation and deposition. This can be
noted from the shapes of protein aggregates that are different from common
fibrillar structures of homogeneous Ab aggregation reported previously
(12), resembling more scattered fibrillar plaques observed in tissues
(35–38).
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% increase of bulk-like water phase following 
Abeta oligomerization
FIGURE 3 Experimental T2 relaxation time of water protons after the
replacement of DX ¼ 0.5%, 4.5%, and 6.5% volume fraction of serum
with water. DX represents the predicted increase of bulklike water phase
after Ab oligomerization (see Eq. 2). The upward shift of T2 measured
by MRS is in excellent agreement with theoretical predictions (see also
Table 1).
2306 Walton et al.elongated aggregates, i.e., protofibrils (indicated by arrows).
At low concentrations, we were not able to discriminate
clearly the amyloid aggregates on transmission EM images.
After three days of incubation at room temperature, Ab
formed larger amyloid structures that deposited at the
bottom of the NMR tubes. A representative EM image
showing such amyloid species is displayed in Fig. 2 b. Back-
ground serum proteins are most likely involved in Ab fibril
formation and deposition. This can be noted from the shapes
of protein aggregates in Fig. 2 b, which are different from
common fibrillar structures of homogeneous Ab aggrega-Biophysical Journal 100(9) 2302–2308tion reported previously (30), and resemble more the scat-
tered plaques observed in tissues (34–38).Ab1-42 oligomerization increases bulklike
to surface/water ratio, inducing longer T2
By using Eq. 2, we estimated the increase of bulklike/surface
water fraction after Ab oligomerization. ForAb volume frac-
tions used in the present experiments, we estimated
DXy0:5% ð5 mM AbÞ;
DXy4:5% ð50 mM AbÞ; andDXy6:5% ð100 mM AbÞ;
respectively. By using Eq. 3 and DX derived as shown in
above, we estimated the increase DT2 in amyloidogenic Ab
systems relative to T2 measured in nonamyloidogenic AbS
mixtures. Predicted DT2 results are in excellent agreement
with experimental T2 data (see Table 1). Moreover, replacing
DX volume fractions of serum with water (which would
represent the increase of bulklike water phase after Ab olig-
omerization), we measured an upward shift of T2 (see Fig. 3)
in the same range as T2 times displayed in Table 1.DISCUSSION
The role water molecules play in protein structure (39–42),
function (39–41), and aggregation (11,12,21–
23,31,32,43,44) is known to be extensive, yet has not been
fully explored. The key experimental feature enabling the
study of water-protein coupling by MRS is encapsulation
of proteins in microscopic water pools (e.g., reverse
micelles) to slow protein hydration dynamics and
Amyloid Oligomers Probed by T2-MRS 2307hydrogen-exchange kinetics (24,25). Our data demonstrated
that a matrix of serum provides an effective environment to
study amyloid oligomer formation, which is also physiolog-
ically relevant. The presence of background serum proteins
increases the fraction of slower water molecules at the
surface of amyloid species, enabling detection.
Recent studies suggested that desolvation effects are
critical to the formation and accumulation of amyloids
(11,12,21–23). Our data show that the presence of amyloido-
genic Ab peptides in serum generates longer T2 relaxation
times of water compared to same concentration mixtures of
serum and nonamyloidogenic AbS (Fig. 1 a). Immunochem-
istrywith oligomer-specific antibodies (Fig. 1 b) andEMdata
(Fig. 2 a) demonstrated that longer T2 correlates with Ab1-42
oligomerization. Our data support a molecular mechanism
for the magnetic contrast of Ab oligomer formation based
on the restructuring of water at interfaces (Fig. 3, Table 1).
The relative increase of bulklike/surface-water shifts T2
toward longer (T2 þ DT2) relaxation times, corresponding
to bulklike water molecules (Fig. 3). Thus, the hyperintense
magnetic signals of water in systems containing amyloido-
genic proteins are early markers of the oligomerization
process. This is the main result of our study. In principle,
the approach could also discriminate between amyloid
oligomers and fibrils, as we predicted previously (22,23).
The amount of released water from interacting interfaces
scales differently for amorphous oligomer versus fibril
formation (22). However, measuring only DT2 shift may
not fully account for such changes. Rather, a plot T2 versus
peptide concentration may prove more relevant for this task.
In contrast to the incipient oligomerization and fibril
formation, the association of amyloid fibrils in tangles and
plaques (which may cage water between constituent fibrils
(44)) is likely to induce hypo-intense MR responses, typical
for structured (bound) water assemblies. MR images of
amyloid samples display indeed both hypo- and hyper-
intense magnetic signals, i.e., dark and bright spots
(34–38,45). The hypo-intense signal is commonly attributed
to the iron present in amyloid plaques, which accelerates the
magnetic relaxation of local water and increases the local
MR contrast (5). Detection of individual oligomers by MR
imaging is technically not feasible currently, due to an insuf-
ficient resolution of the MR imaging scanners (46).
This study shows that structural changes associated with
oligomer formation have a unique impact on the overall
proton MR signal reflected in the upward shift of the char-
acteristic T2 relaxation time of bulklike water. Thus, the
presence of multiple, dynamically labile preamyloid struc-
tures in the environment may induce sizeable MR contrast
to enable detection, if susceptible tissues for amyloid
oligomer accumulation are identified sufficiently early.
Immunofluorescence micrographs of AD human brain
tissues clearly show closely packed preamyloid oligomers
spreading on hundred-mm2 size domains (7), which is
normally accessible by MR imaging scanners (34–38).Our results may give further impetus to the development
of noninvasive techniques for identifying pathogenic
proteins related to disease. For instance, water proton
MRS tools and experimental protocols can be tuned to
detect efficiently MR signal(s) of water molecules next to
hydrophobic patches. This may prove extremely valuable
in discriminating between toxic amyloid oligomers, which
have an increased hydrophobic character (47), and other
hydrophilic oligomers that have a lower propensity to attach
to membranes and induce toxicity (47). Moreover, decipher-
ing the magnetic relaxation response of water surrounding
various embryonic amyloid species is important in fields
as diverse as protein folding (39–42) and surface science
(48,49).
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